Korea United Pharm Inc
KRX:033270
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
20 550
27 550
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is 43 960.93 KRW. Compared to the current market price of 20 550 KRW, Korea United Pharm Inc is Undervalued by 53%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Korea United Pharm Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Korea United Pharm Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Korea United Pharm Inc
Balance Sheet Decomposition
Korea United Pharm Inc
Current Assets | 245.1B |
Cash & Short-Term Investments | 133.8B |
Receivables | 49.3B |
Other Current Assets | 62.1B |
Non-Current Assets | 240.9B |
Long-Term Investments | 74.2B |
PP&E | 151B |
Intangibles | 9.2B |
Other Non-Current Assets | 6.5B |
Current Liabilities | 79.8B |
Accounts Payable | 16.6B |
Accrued Liabilities | 18.1B |
Other Current Liabilities | 45B |
Non-Current Liabilities | 19.6B |
Long-Term Debt | 14.7B |
Other Non-Current Liabilities | 4.9B |
Earnings Waterfall
Korea United Pharm Inc
Revenue
|
285.8B
KRW
|
Cost of Revenue
|
-122.7B
KRW
|
Gross Profit
|
163.1B
KRW
|
Operating Expenses
|
-107.3B
KRW
|
Operating Income
|
55.8B
KRW
|
Other Expenses
|
-23.6B
KRW
|
Net Income
|
32.2B
KRW
|
Free Cash Flow Analysis
Korea United Pharm Inc
KRW | |
Free Cash Flow | KRW |
Profitability Score
Profitability Due Diligence
Korea United Pharm Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Korea United Pharm Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Korea United Pharm Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.
Score
Korea United Pharm Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Korea United Pharm Inc
According to Wall Street analysts, the average 1-year price target for Korea United Pharm Inc is 37 740 KRW with a low forecast of 37 370 KRW and a high forecast of 38 850 KRW.
Dividends
Current shareholder yield for Korea United Pharm Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is 43 960.93 KRW.
Compared to the current market price of 20 550 KRW, Korea United Pharm Inc is Undervalued by 53%.